Profil
Gegenwärtig ist Birgitte Volck SVP, Head-Clinical Development & Medical Affairs bei Ascendis Pharma A. Dr. Volck ist außerdem Mitglied des Vorstands von Soleno Therapeutics, Inc. und Vaccibody AS. Zuvor war Dr. Volck Leiterin der Forschung und Entwicklung bei GlaxoSmithKline Plc, Chief Medical Officer & Senior VP-Development bei Swedish Orphan Biovitrum AB, President-Research & Development bei Avrobio, Inc, Director-Executive Development bei Amgen, Inc, Director-Nordic Medical & Project Director bei Genzyme Danmark und Head-Clinical Development & Medical Affairs bei Pharmexa A. Birgitte Volck promovierte an der Universität von Kopenhagen.
Aktive Positionen von Birgitte Volck
| Unternehmen | Position | Beginn |
|---|---|---|
| EGETIS THERAPEUTICS AB | Direktor/Vorstandsmitglied | 01.01.2026 |
Ehemalige bekannte Positionen von Birgitte Volck
| Unternehmen | Position | Ende |
|---|---|---|
| SOLENO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 15.05.2026 |
OMass Therapeutics Ltd.
OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops native mass spectrometry platform | Direktor/Vorstandsmitglied | 28.01.2026 |
| NYKODE THERAPEUTICS | Direktor/Vorstandsmitglied | 30.12.2024 |
| ASCENDIS PHARMA A/S | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2023 |
| TECTONIC THERAPEUTIC, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2020 |
Ausbildung von Birgitte Volck
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 15 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Soleno Therapeutics, Inc.
Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Pharmexa A/S
Pharmexa A/S Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TFS Trial Form Support AB
TFS Trial Form Support AB Miscellaneous Commercial ServicesCommercial Services Provides clinical trial and contract research services | Commercial Services |
Ascendis Pharma A/S
Ascendis Pharma A/S Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes therapies for metabolic, cardiovascular and ophthalmology | Health Technology |
Nykode Therapeutics ASA
Nykode Therapeutics ASA Pharmaceuticals: MajorHealth Technology Develops vaccines and immunotherapy against infectious diseases and cancer | Health Technology |
TFS Trial Form Support International AB
TFS Trial Form Support International AB Miscellaneous Commercial ServicesCommercial Services Operates as clinical contract research organization | Commercial Services |
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
Egetis Therapeutics AB
Egetis Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company | Health Technology |
Genzyme Danmark | |
Wilson Therapeutics AB
Wilson Therapeutics AB Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focusing in treatment of Wilson disease | Health Technology |
AVROBIO, Inc.
AVROBIO, Inc. BiotechnologyHealth Technology Develops potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases in a single dose | Health Technology |
OMass Therapeutics Ltd.
OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops native mass spectrometry platform | Commercial Services |
















